CN105838355A - Micromolecule fluorescent probe and application thereof - Google Patents

Micromolecule fluorescent probe and application thereof Download PDF

Info

Publication number
CN105838355A
CN105838355A CN201610285502.2A CN201610285502A CN105838355A CN 105838355 A CN105838355 A CN 105838355A CN 201610285502 A CN201610285502 A CN 201610285502A CN 105838355 A CN105838355 A CN 105838355A
Authority
CN
China
Prior art keywords
fluorescent probe
hsa
probe
small
molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201610285502.2A
Other languages
Chinese (zh)
Other versions
CN105838355B (en
Inventor
杜健军
朱涛
彭孝军
樊江莉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dalian University of Technology
Original Assignee
Dalian University of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dalian University of Technology filed Critical Dalian University of Technology
Priority to CN201610285502.2A priority Critical patent/CN105838355B/en
Publication of CN105838355A publication Critical patent/CN105838355A/en
Application granted granted Critical
Publication of CN105838355B publication Critical patent/CN105838355B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34Oxygen atoms
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6486Measuring fluorescence of biological material, e.g. DNA, RNA, cells
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1029Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
    • C09K2211/1037Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom with sulfur

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Materials Engineering (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Abstract

The invention discloses a micromolecule fluorescent probe and application thereof .The fluorescent probe is of the structure shown in the general formula I based on the TICT mechanism .Background fluorescence of the micromolecule fluorescent probe is weak in PBS buffer liquid, and the fluorescence intensity is obviously increased after the probe enters a hydrophobic cavity of human serum albumin HSA .The micromolecule fluorescent probe is good in selectivity and not disturbed by other common amino acid and protein molecules .In addition, response time is short after the probe interacts with HSA, and the probe can achieve specific binding of a FA1 locus of HSA .In the PBS buffer liquid, the fluorescence intensity and the HSA concentration show the good linear relation, and accurate detection can be achieved for human serum albumin HSA .In the real urine testing environment, the fluorescence intensity of the micromolecule fluorescent probe and albumin concentration in urine have the good linear relation, and therefore the micromolecule fluorescent probe has the good biological application prospect.

Description

Small molecule fluorescent probe and application thereof
Technical field
The present invention relates to field of fine chemical fluorescent probe, Preparation Method And The Use, particularly relate to a class based on The small-molecule fluorescent probe of TICT mechanism, preparation method and the application in terms of albumin labelling and detection by quantitative thereof.
Background technology
Detection technique of fluorescence have highly sensitive, selectivity good, method is simple, in situ and the advantage such as detection in real time, Become requisite detection means in modern biotechnology and life science.In protein labeling technology, glimmering Cursor notation has obvious advantage relative to other traditional labeling methods, increasingly causes the concern of researcher.
Human serum albumin HSA is the protein that in serum, content is most, and its content in serum is at 30-50g/L Left and right.Due to the Dialysis of kidney, in urine, albuminous content is at below 30mg/L.Albuminous physiology Function includes maintaining the osmotic pressure of blood vessel, balanced nutritious, transport medicine and metabolite.Meanwhile, Microalbunin in urine White content is relevant with kidney disease and diabetes, can be as kidney disease early treatment and intensification therapy of diabetes mellitus patients Key index.Therefore its accurately detection in urine has very important biology and medical significance.
Imaging-PAM is the microanalysis skill that people provide that a kind of selectivity is good, highly sensitive, detection limit is low Art, it has been widely used in the analysis detection of biomacromolecule such as protein, DNA and RNA.In document The side's of having been reported that type dye, BODIPY class dyestuff and the albuminous detection in aqueous phase of polar sensitive probe.But send out Now have good fluorescence character (such as high quantum production rate, long wavelength and stable in properties etc.), convieniently synthesized, can be low dense The degree albuminous fluorescent probe of lower detection still faces the challenge.We have synthesized class HSA based on TICT mechanism Fluorescent probe, it can realize the fluorescence response of OFF-ON in PBS.Such probe is convieniently synthesized, Only need one-step or two-step reaction the most available, therefore there are good economic benefits.It addition, such probe has TICT structure, while to HSA inner apolar environment sensitive, intramolecular freely rotatable can be empty by protein Chamber is suppressed, and has relatively low detection limit and good sensitivity.In addition, by introducing rhodanine electron-withdrawing group Group, it is achieved that probe is specific binding to HSA FA1 site, provides with protein bound mode for research dyestuff New approach.
Summary of the invention
It is desirable to provide class small-molecule fluorescent probe based on TICT mechanism, can be used for human seralbumin in aqueous phase The detection by quantitative of albumen HSA.
Present invention firstly provides small molecule fluorescent probe, there is following general structure I:
In formula I:
R1-R7It is each independently selected from H, C1-8Alkyl, replacement or unsubstituted phenyl;
Described substituted-phenyl is arbitrarily replaced by following group: CN, COOH, NH2、NO2、OH、SH、C1-6Alkane Epoxide, C1-6Alkyl amino, C1-6Amide groups, halogen or C1-6Haloalkyl;
X is oxygen or sulfur;
N is selected from the integer of 1-8.
On the other hand, the present invention provides the preparation method of above-mentioned small-molecule fluorescent probe, is at toluene, ammonium acetate and ice In the mixed system of acetic acid, compounds of formula II and compounds of formula III react gained:
Fluorescent probe of the present invention background fluorescence in PBS is more weak, at the hydrophobic cavity entering HSA After, there is obvious Fluorescence Increasing, and its fluorescence intensity has good linear relationship with protein concentration, the most right Other macro-molecular proteins and each amino acid have good selectivity, and are not done by internal common zwitterion Disturb.It addition, its with HSA effect after response time shorter, and can tie with the FA1 locus specificity of HSA Close.In PBS, its fluorescence intensity shows good linear relationship, to human serum with the concentration of HSA Albumin HAS can receive orders detection.Under the test environment of true urine, its fluorescence intensity is dense with albumin in urine Degree agriculture poplar has good linear relationship, therefore has good biologic applications prospect.In consideration of it, the present invention further side The purpose in face is to provide the application in preparation Protein Detection compositions of described small-molecule fluorescent probe.And based on This, it is provided that a kind of compositions for albumin detection, said composition includes that the small molecule fluorescent of the invention described above is visited Pin.Described compositions is particularly suited for the inspection of the microalbumin in human serum albumin (HSA) and urine sample Survey.
TICT mechanism small-molecule fluorescent probe of the present invention has a following significant feature:
(1) almost without fluorescence in PBS buffer solution, after entering protein cavity, there is obvious Fluorescence Increasing;
(2) probe fluorescence intensity in buffer and protein concentration present good linear relationship, can be used for white egg White detection by quantitative;
(3) selectivity is good, to other protein and aminoacid almost without response;
(4) can be combined with albuminous FA1 locus specificity, the model of action for research dyestuff with protein carries Supply powerful method;
(5) convieniently synthesized, product is easy to get.
Accompanying drawing explanation
Accompanying drawing 8 width of the present invention,
Fig. 1 be performance measurement experiment 1 in fluorescent probe compounds ES1, ES2, ES3 to human serum albumin (HSA) Fluorescence titration experiment test figure.The concentration of probe molecule is 5 μMs, test system be in PBS buffer solution (pH=7.4, 10mM), the excitation wavelength of probe molecule ES1 be the excitation wavelength of 474nm, ES2 be 507nm, ES3 swash Sending out wavelength is 430nm.
Fig. 2 be performance measurement experiment 2 in fluorescent probe compounds ES1 to human serum albumin (HSA) and difference Aminoacid selectivity experiment block diagram.Probe molecule ES1 concentration is 5 μMs, and the concentration of HSA is 5 μMs, other Amino acid whose concentration is 50 μMs.Excitation wavelength is 474nm, gathers the fluorescence intensity at 547nm.
Fig. 3 be performance measurement experiment 3 in fluorescent probe compounds ES1 to human serum albumin (HSA) and difference The selectivity experiment block diagram of protein.Probe molecule ES1 concentration is 5 μMs, HSA and the concentration of other protein For being 5 μMs.Excitation wavelength is 474nm, the fluorescence intensity at record 547nm.
Fig. 4 is that in performance measurement experiment 4, fluorescent probe compounds ES1 is combined ratio in fact with human serum albumin HSA Test figure.The total concentration of fixing probe molecule ES1 Yu HSA is 10 μMs, constantly changes the concentration of probe and HSA Ratio, respectively 1:9,2:8,3:7,4:6,5:5,6:4,7:3,8:2,9:1.Excitation wavelength is 474nm, record Fluorescence intensity at 547nm.
Fig. 5 is fluorescent probe compounds ES1 and the positioning experiment of human serum albumin HSA in performance measurement experiment 5 Figure.Probe molecule concentration is 10 μMs, adds 2 μMs of HSA and makes itself and probe mixing 1h.Replace the concentration of medicine It is respectively 5,10,15,20,30,40,60,80 μMs.
Fig. 6 is fluorescent probe compounds ES1 and human serum albumin HSA compound system pair in performance measurement experiment 6 The response diagram of temperature.The concentration of probe molecule and HSA is 5 μMs, temperature chooses 20 respectively, 25,30, 35,40,45,50 degrees Celsius.
Fig. 7 is the fluorescent probe compounds ES1 time response to human serum albumin HSA in performance measurement experiment 7 Figure.The concentration of probe molecule is 5 μMs, and the concentration of the HSA of addition is 5 μMs.Abscissa is time (min), Vertical coordinate is fluorescence intensity.
Fig. 8 is that in performance measurement experiment 8, fluorescent probe compounds ES1 is sensitive to the detection of human serum albumin HSA Degree lab diagram.The concentration of probe molecule is 5 μMs.Figure a is to visit in (pH=7.4,10mM) in PBS buffer solution Linear relationship between fluorescence intensity and the HSA concentration of pin molecule;Figure b is the fluorescence of true urine middle probe molecule Linear relationship between intensity and HSA concentration.Excitation wavelength is 474nm, the fluorescence intensity at record 547nm.
Detailed description of the invention
Unless otherwise indicated, term used herein has following meanings.
Unless otherwise indicated, term used herein has following meanings.
Term used herein " alkyl " includes straight chained alkyl and branched alkyl.As mentioned by single alkyl such as " third Base ", the most only refer in particular to straight chained alkyl, as mentioned by single branched alkyl such as " isopropyl ", the most only refer in particular to branched alkyl.Example As, " C1-4Alkyl " include methyl, ethyl, n-pro-pyl, isopropyl, normal-butyl and the tert-butyl group etc..Similar rule It is also applied in this specification other group used.
Small-molecule fluorescent probe of the present invention, has a following general structure I:
In formula I: R1-R7It is each independently selected from H, C1-8Alkyl, replacement or unsubstituted phenyl;
Described substituted-phenyl is arbitrarily replaced by following group: CN, COOH, NH2、NO2、OH、SH、C1-6Alkane Epoxide, C1-6Alkyl amino, C1-6Amide groups, halogen or C1-6Haloalkyl;
In detailed description of the invention, described R1-R4It is each independently selected from H or C1-4Alkyl, preferably H or methyl, Most preferably H.
In detailed description of the invention, described R5And R6It is each independently selected from C1-4Alkyl, preferably methyl or ethyl, Most preferable.
In detailed description of the invention, described R7Selected from H or C1-4Alkyl, preferably H or methyl, most preferably H.
In formula I, described X is oxygen or sulfur, preferably S.
In formula I, described n selected from the integer of 1-8, the integer of preferably 1-3, particularly preferred 1 or 2, most preferably 1。
Each preferred feature described above can be mutually combined, and gained technical scheme should be included in this completely Bright addressed scope.
The example of the combination of preferred feature, for specific embodiment of the present invention one of be, of the present invention little Fluorescence probe, selected from following compound:
On the other hand, the present invention provides the preparation method of described small-molecule fluorescent probe, is at toluene, ammonium acetate and ice In the mixed system of acetic acid, compounds of formula II and compounds of formula III react gained:
In detailed description of the invention, the molar ratio of described compound II and compound III is 0.1-1000:1, preferably For 0.5-100:1, more preferably 0.5-10:1, further preferably 1-5:1, most preferably 1.5:1, there is condensation reaction, generate in the two General structure is the target compound of I.
More than reaction can be carried out in aqueous organic solvent or anhydrous organic solvent.It is preferably anhydrous organic solvent. Organic solvent includes but are not limited to toluene, benzene, dichloromethane, oxolane or acetonitrile etc., and preferably reaction dissolvent is Toluene.Course of reaction judges the terminal of reaction by thin layer chromatography (TLC).
Above-mentioned reaction temperature is-10 DEG C-150 DEG C, preferably 111 DEG C-130 DEG C;React optional acidity or base catalyst is Triethylamine, piperidines, ammonium acetate, sodium acetate and glacial acetic acid, preferred catalyst is ammonium acetate and glacial acetic acid mixed system.
The method of purification of the small molecule fluorescent dyestuff of the present invention uses conventional method, is not particularly limited.Generally, instead After should terminating, after directly filtering or boiling off solvent, utilize chromatographic column separating-purifying product.
Gained fluorescent dye can be reclaimed by separation well known in the art and purification technique, to reach the purity needed.
The various raw materials used in the present invention are all commercially available, or can be by the side of well known to a person skilled in the art Method disclosed in method or prior art is prepared simply by raw material well known in the art.
It should be understood that the various ring substituents in the compounds of this invention have some can before above-mentioned steps is carried out or just After completing, being introduced by the aromatics substitution reaction of standard or produced by conventional modified with functional group, this is included in The method step aspect of the present invention.This reaction and modification include such as substituent group by the introducing of aromatics substitution reaction, The reduction of substituent group, the alkylation of substituent group and the oxidation of substituent group.Reagent and reaction condition for these processes are Known to chemical field.The instantiation of aromatics substitution reaction includes introducing nitro, with such as carboxylic acid halides and road with concentrated nitric acid Lewis acid (such as aluminum chloride) introduces acyl group under the conditions of Friedel Crafts, with alkyl halide and lewis acid (such as trichlorine Change aluminum) under the conditions of Friedel Crafts, introduce alkyl, and introduce halogen group.The instantiation modified includes passing through Such as carry out catalytic hydrogenation with Raney nickel or carry out heat treated with ferrum in presence of hydrochloric acid, nitro is reduced ammonification Base;Alkylthio group is oxidized to alkyl sulphinyl or alkyl sulphonyl.
Small-molecule fluorescent probe based on TICT mechanism as herein described has obvious fluorescence after entering albumin cavity Recover, can be used for the detection by quantitative of microalbumin in urine.
Following non-limiting example can make those of ordinary skill in the art that the present invention be more fully understood, but not Limit the present invention by any way.
Embodiment 1
The synthesis of fluorescent probe compounds ES1:
Dimethylamino benzaldehyde (1.49g, 10mmol) and rhodanine (1.33g, 10mmol) will be equipped with In the round-bottomed flask of 10mL toluene, add 200mg ammonium acetate and 1mL glacial acetic acid as catalyst, be warmed up to 115 DEG C of back flow reaction.Reaction 24h, removes solvent, chromatographic column isolated red solid ES1 (78.25%) under reduced pressure.1H NMR (500MHz, DMSO-D6), δ: 3.04 (s, 6H), 4.27 (s, 1H), 6.82 (t, J=10Hz, 2H), 7.42 (t, J=10Hz, 2H), 7.53 (s, 1H);13C NMR(500MHz,DMSO-D6),δ:112.172,117.313, 119.757,132.872,133.253,151.759,169.371,176.645,194.973,105.280ppm;TOF MS:m/z calcd for[M+H]+:265.0469,found:265.0458.
Embodiment 2
The synthesis of fluorescent probe compounds ES2:
4-di methyl amino cinnamaldehyde (1.75g, 10mmol) is added dress with rhodanine (1.33g, 10mmol) Have in the round-bottomed flask of 12mL toluene, add 200mg ammonium acetate and 1mL glacial acetic acid as catalyst, intensification To 115 DEG C of back flow reaction.Reaction 24h, removes solvent, chromatographic column isolated dark brown solid ES2 (65.46%) under reduced pressure.1H NMR (500MHz, DMSO-D6), δ: 2.99 (s, 6H), 3.10 (q, J=25Hz, 1H), 6.72 (d, J=5Hz, 3H), 7.21 (q, J=45Hz, 2H), 7.51 (d, J=10Hz, 2H);13C NMR(500MHz,DMSO-D6),δ: 45.75,111.89,112.10,118.48,123.31,129.41,129.73,130.97,145.41,151.45ppm;TOF MS:m/z calcd for[M+H]+:291.0626,found:291.0618.
Embodiment 3
The synthesis of fluorescent probe compounds ES3:
Will be to dimethylamino benzaldehyde (1.49g, 10mmol) and 2,4-thiazolidinedione (1.17g, 10mmol) It is equipped with in the round-bottomed flask of 10mL toluene, adds 200mg ammonium acetate and 1mL glacial acetic acid as catalysis Agent, is warmed up to 115 DEG C of back flow reaction.Reaction 24h, removes solvent, chromatographic column isolated yellow solid under reduced pressure ES3 (85.60%).1H NMR (500MHz, DMSO-D6), δ: 3.01 (s, 6H), 6.83 (d, J=10Hz, 2H), 7.42 (d, J=5Hz, 2H), 7.67 (s, 1H), 12.31 (s, 1H);13C NMR(500MHz,DMSO-D6),δ: 110.79,110.91,111.95,120.02,115.63,119.79,132.10,132.91,133.82,139.29,151.44, 167.48,168.11ppm;TOF MS:m/z calcd for[M-H]-:247.0541,found:247.0545.
Embodiment 4
Human serum albumin (HSA) fluorescence titration is tested by fluorescent probe compounds ES1, ES2 and ES3
5 μMs of small-molecule fluorescent probe ES1, ES2 and ES3 are joined (pH=7.4,10 in PBS buffer solution MM), it is gradually added into the HSA of variable concentrations, as it is shown in figure 1,1a, 1b and 1c are respectively dyestuff ES1, ES2 With the ES3 fluorescence response figure to serum albumin HSA.The excitation wavelength of three example dyestuffs is respectively 474nm, 507nm And 430nm.Along with the increase of HSA concentration, the fluorescence intensity at probe molecule maximum emission peak gradually strengthens.
Embodiment 5
The selectivity of human serum albumin (HSA) and different aminoacids is tested by fluorescent probe compounds ES1
The compound ES1 using above-mentioned synthesis evaluates the selectivity to different aminoacids: by 5 μMs of probe compounds ES1 and 5 μMs of HSA and 50 μMs of variety classes aminoacid (glutamic acid, glycine, histidine, tryptophan, Arginine, tyrosine, aspartic acid, agedoite, cysteine and lysine) join PBS In (pH=7.4,10mM), the excitation wavelength of probe is 474nm, chooses a length of 547nm of transmitted wave, records phase The fluorescence intensity change answered.Test result is as in figure 2 it is shown, after adding 5 μMs of human serum albumin HSAs, visit The fluorescence intensity of pin increases 72 times, and the fluorescence that 50 μMs of amino acid whose additions of variety classes can't affect probe is strong Degree.
Embodiment 6
The selectivity of human serum albumin (HSA) and different proteins is tested by fluorescent probe compounds ES1
The compound ES1 using above-mentioned synthesis evaluates the selectivity to different proteins: by 5 μMs of probe compounds ES1 and 5 μMs of HSA and variety classes protein are (bovine serum albumin BSA, Chymotrypsin, protease, molten Bacterium enzyme, chymotrypsinogen A, hemoglobin and histone) join (pH=7.4,10 in PBS MM), the excitation wavelength of probe is 474nm, chooses a length of 547nm of transmitted wave, records corresponding fluorescence intensity and becomes Change.Test result as it is shown on figure 3, owing to having similar structure and biological property, probe show HSA and The high selectivity of BSA, when i.e. only adding HSA and BSA, probe compound just has obvious Fluorescence Increasing. It addition, the fluorescence response different to HSA with BSA by comparing probe compound ES1, it has been found that add 5 After μM HSA, the fluorescence intensity of probe increases 60 times, and 5 μMs of BSA are only capable of making the fluorescence intensity of probe to increase 6 times, illustrate that probe compound ES1 has more preferable selectivity to HSA.
Embodiment 7
Fluorescent probe compounds ES1 is combined Ratio Experiments with human serum albumin HSA
Use the combination ratio of compound ES1 checking probe molecule and the human serum albumin of above-mentioned synthesis: Job ' s plot Experiment is a kind of method for determining two kinds of material stoichiometric proportions.PBS (pH=7.4,10 MM), in test system, the total concentration of fixing probe molecule ES1 Yu HSA is 10 μMs, constantly changes probe With the concentration ratio of HSA, respectively 1:9,2:8,3:7,4:6,5:5,6:4,7:3,8:2,9:1, test its phase The change of the fluorescence spectrum answered.As it can be seen, when the concentration ratio of probe molecule and HSA is during for 5:5, fluorescence intensity The strongest, this explanation probe molecule ES1 with HSA is to be combined with the ratio of 1:1.
Embodiment 8
Fluorescent probe compounds ES1 and the positioning experiment of human serum albumin HSA
Use the compound ES1 checking probe molecule of above-mentioned synthesis and the binding site of human serum albumin: select four Planting different pharmaceutical, i.e. warfarin, ibuprofen, propofol and hemin and replace Experimental agents as medicine, they are respectively Can be combined with FA7, FA3/4 and FA6 of human serum albumin HSA, FA3/4 and FA5 and FA1 site. In the test system of PBS (pH=7.4,10mM), probe molecule concentration is 10 μMs, adds 2 μM HSA makes itself and probe mixing 1h, it is ensured that both effects completely.Add in above-mentioned supramolecular system subsequently Four kinds of medicines of variable concentrations (5,10,15,20,30,40,60,80 μMs), the change of the fluorescence intensity of recording responses.As Shown in Fig. 5, in the probe molecule mixed system with HSA, add the warfarin of variable concentrations, ibuprofen and the third pool The fluorescence intensity of mixed system is had little to no effect by phenol, and hemin can the fluorescence of substantially cancellation system, probe is described Compound ES1 is combined in FA1 site with human serum albumin HSA, for research dye molecule and protein Interact and provide new method.
Embodiment 9
After fluorescent probe compounds ES1 and human serum albumin HSA effect, temperature-responsive is tested
The compound ES1 using above-mentioned synthesis evaluates after probe molecule acts on human serum albumin real to temperature-responsive Test.According to the literature, the fluorescence intensity of the molecule with TICT character often shows the sensitivity to temperature. In the test system of PBS (pH=7.4,10mM), probe molecule and the concentration of human serum albumin It is 5 μMs, adjusts the temperature of test system the most from high to low and from low to high, the temperature of selection is respectively 20, 25,30,35,40,45 and 50 degrees Celsius.From Fig. 6 a, when temperature gradually rises, probe molecule with The fluorescence intensity of protein complex system is gradually lowered, by Fig. 6 b, when temperature is gradually lowered, probe molecule and egg The fluorescence intensity of white matter compound system gradually rises.
Embodiment 10
The response time of human serum albumin HSA is tested by fluorescent probe compounds ES1
The compound ES1 using above-mentioned synthesis evaluates the response time of probe molecule and HSA effect: buffer at PBS In the test system of liquid (pH=7.4,10mM), probe molecule concentration is 5 μMs, and excitation wavelength is 474nm, The change of fluorescence intensity at record 547nm.As shown in Figure 7, after adding 5 μMs of protein, probe molecule pair The response of human serum albumin HSA is quite rapid, i.e. can reach balance in about 10s fluorescence intensity, and subsequently At least 60min in keep constant.
Embodiment 11
The fluorescent probe compounds ES1 detection sensitivity to human serum albumin HSA
The compound ES1 using above-mentioned synthesis evaluates the probe molecule detection sensitivity to HSA: first delay at PBS Rushing in the test system of liquid (pH=7.4,10mM), the concentration of dyestuff is 10 μMs, is separately added into above-mentioned system Concentration is 0.002,0.004,0.006,0.008,0.013,0.018,0.023,0.028 and 0.033mg/mL, Excitation wavelength is 474nm, the fluorescence intensity change at record 547nm.As shown in Figure 8 a, the fluorescence intensity of probe Along with the increase of HSA concentration gradually strengthens, and its fluorescence intensity and human serum albumin HSA are at 0-0.033 There is in the range of mg/mL good linear relationship (R2=0.997).Calculate detection be limited to by 3 σ/k simultaneously 0.132mg/L, therefore probe molecule ES1 can be used for the detection by quantitative of low concentration HSA.It addition, we also investigate Compound ES1 is in response condition to HSA of true urine test system.We select healthy male volunteers to carry The urine specimen of confession, using clinical method to record the content of microalbumin in this urine specimen is 0.0035 Mg/mL, and as benchmark, in above-mentioned system, add 10 μMs of probe molecule ES1, be subsequently added variable concentrations The HSA of (0.005,0.01,0.015,0.025,0.035,0.045 and 0.055mg/mL), excitation wavelength is 474nm, the fluorescence intensity change at record 547nm.As shown in Figure 8 b, in the test system of true urine Side, the fluorescence intensity of probe molecule ES1 has good linear relationship as the concentration of human serum albumin HSA (R2=0.999), illustrate that probe compound ES1 has good biologic applications.

Claims (9)

1. small molecule fluorescent probe, has a following general structure I:
In formula I:
R1-R7It is each independently selected from H, C1-8Alkyl, replacement or unsubstituted phenyl;
Described substituted-phenyl is arbitrarily replaced by following group: CN, COOH, NH2、NO2、OH、SH、C1-6Alkane Epoxide, C1-6Alkyl amino, C1-6Amide groups, halogen or C1-6Haloalkyl;
X is oxygen or sulfur;
N is selected from the integer of 1-8.
Small-molecule fluorescent probe the most according to claim 1, it is characterised in that described R1-R7The most independent Ground is selected from H or C1-4Alkyl.
Small-molecule fluorescent probe the most according to claim 2, it is characterised in that described R1-R4、R7Each Independently selected from H or methyl.
Small-molecule fluorescent probe the most according to claim 2, it is characterised in that described R5And R6The most solely On the spot selected from C1-4Alkyl.
Small-molecule fluorescent probe the most according to claim 1, it is characterised in that described n is whole selected from 1-3's Number.
Small-molecule fluorescent probe the most according to claim 1, selected from following compound:
7. the preparation method of the small-molecule fluorescent probe described in claim 1, it is characterised in that be at toluene, acetic acid In the mixed system of ammonium and glacial acetic acid, compounds of formula II and compounds of formula III react gained:
8. the application in preparation Protein Detection compositions of the small-molecule fluorescent probe described in claim 1.
9. for the compositions of albumin detection, including the small-molecule fluorescent probe described in claim 1.
CN201610285502.2A 2016-04-29 2016-04-29 Small molecule fluorescence probe and its application Active CN105838355B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610285502.2A CN105838355B (en) 2016-04-29 2016-04-29 Small molecule fluorescence probe and its application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610285502.2A CN105838355B (en) 2016-04-29 2016-04-29 Small molecule fluorescence probe and its application

Publications (2)

Publication Number Publication Date
CN105838355A true CN105838355A (en) 2016-08-10
CN105838355B CN105838355B (en) 2018-06-22

Family

ID=56590692

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610285502.2A Active CN105838355B (en) 2016-04-29 2016-04-29 Small molecule fluorescence probe and its application

Country Status (1)

Country Link
CN (1) CN105838355B (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110372681A (en) * 2019-07-29 2019-10-25 天津医科大学 A kind of application of the self-assembled nanometer fluorescence probe for selective enumeration method human serum albumins
CN110386931A (en) * 2018-04-20 2019-10-29 南京大学 A kind of human albumin's fluorescence probe and its preparation method and purposes
CN112823278A (en) * 2018-08-27 2021-05-18 香港科技大学 Method for detecting human serum albumin in biological liquid
WO2021175203A1 (en) * 2020-03-02 2021-09-10 The Hong Kong University Of Science And Technology Aie probe and application thereof
CN114940686A (en) * 2022-05-13 2022-08-26 西北工业大学深圳研究院 Photodynamic physiotherapy micromolecule and preparation method and use method thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004014175A (en) * 2002-06-04 2004-01-15 Nippon Kayaku Co Ltd Dye-sensitized photoelectric conversion element
US20130287727A1 (en) * 2012-04-25 2013-10-31 Inscent, Inc. Psyllid Attractants and Their Uses
KR20160021542A (en) * 2014-08-18 2016-02-26 삼성에스디아이 주식회사 Novel compound, photosensitive resin composition and color fliter
CN105462394A (en) * 2015-12-30 2016-04-06 辛范范 Scrubbing-resistant latex paint and preparation method thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004014175A (en) * 2002-06-04 2004-01-15 Nippon Kayaku Co Ltd Dye-sensitized photoelectric conversion element
US20130287727A1 (en) * 2012-04-25 2013-10-31 Inscent, Inc. Psyllid Attractants and Their Uses
KR20160021542A (en) * 2014-08-18 2016-02-26 삼성에스디아이 주식회사 Novel compound, photosensitive resin composition and color fliter
CN105462394A (en) * 2015-12-30 2016-04-06 辛范范 Scrubbing-resistant latex paint and preparation method thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
SURENDER SINGH JADAV等: "Thiazolidone derivatives as inhibitors of chikungunya virus", 《EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY》 *
SWARNA LATHA G等: "Synthesis and antioxidant activity of 1,3-thiazolidine-2,4-dione derivatives", 《JOURNAL OF PHARMACY AND CHEMISTRY》 *
VEISI.HOJAT等: "Synthesis of 5-Alkylidene-2,4-thiazolidinediones and Rhodanines Promoted by Propylamino-functionalized Nano-structured SBA-15", 《ORGANIC PREPARATIONS AND PROCEDURES INTERNATIONAL》 *

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110386931A (en) * 2018-04-20 2019-10-29 南京大学 A kind of human albumin's fluorescence probe and its preparation method and purposes
CN110386931B (en) * 2018-04-20 2022-04-22 南京大学 Human serum protein fluorescent probe and preparation method and application thereof
CN112823278A (en) * 2018-08-27 2021-05-18 香港科技大学 Method for detecting human serum albumin in biological liquid
CN110372681A (en) * 2019-07-29 2019-10-25 天津医科大学 A kind of application of the self-assembled nanometer fluorescence probe for selective enumeration method human serum albumins
CN110372681B (en) * 2019-07-29 2022-06-07 天津医科大学 Application of self-assembled nano fluorescent probe for selectively detecting human serum albumin
WO2021175203A1 (en) * 2020-03-02 2021-09-10 The Hong Kong University Of Science And Technology Aie probe and application thereof
CN114940686A (en) * 2022-05-13 2022-08-26 西北工业大学深圳研究院 Photodynamic physiotherapy micromolecule and preparation method and use method thereof
CN114940686B (en) * 2022-05-13 2023-11-28 西北工业大学深圳研究院 Photodynamic physiotherapy small molecule and preparation method and use method thereof

Also Published As

Publication number Publication date
CN105838355B (en) 2018-06-22

Similar Documents

Publication Publication Date Title
CN105838355A (en) Micromolecule fluorescent probe and application thereof
Yang et al. Recent advances in multifunctional fluorescent probes for viscosity and analytes
Gavrilyuk et al. Formylbenzene diazonium hexafluorophosphate reagent for tyrosine-selective modification of proteins and the introduction of a bioorthogonal aldehyde
Usama et al. Norcyanine-carbamates are versatile near-infrared fluorogenic probes
Er et al. Fluorescent dye cocktail for multiplex drug-site mapping on human serum albumin
Samanta et al. Solo smart fluorogenic probe for potential cancer diagnosis and tracking in vivo tumorous lymphatic systems via distinct emission signals
Yu et al. Self-assembled nanostructures based on activatable red fluorescent dye for site-specific protein probing and conformational transition detection
Xu et al. A fluorescent sensor for discrimination of HSA from BSA through selectivity evolution
Huang et al. A selective and sensitive fluorescent probe for the determination of HSA and trypsin
Sun et al. Highly selective fluorescent turn-on probe for protein thiols in biotin receptor-positive cancer cells
Guo et al. Self-assembled nanosensor based on squaraine dye for specific recognition and detection of human serum albumin
Liao et al. A specific and biocompatible fluorescent sensor based on the hybrid of GFP chromophore and peptide for HSA detection
CN105572095B (en) A kind of detection reagent and quantitative detecting method of human serum albumins
CN106699734B (en) Fluorescent molecular probe and nano probe as well as preparation method and application thereof
Fujita et al. Hydrated ionic liquids enable both solubilisation and refolding of aggregated concanavalin A
CN105712964A (en) Preparation method and application of mercaptan fluorescence probe based on coumarin
Song et al. Anaphthalimide-based fluorescent probe for mercapto-containing compounds
Zheng et al. A Bioresponsive Near‐Infrared Fluorescent Probe for Facile and Persistent Live‐Cell Tracking
US9791451B2 (en) Squaraine based fluorescent probe and a process for the preparation thereof
EP1520176B1 (en) Reagents and a method for saturation labelling of proteins
Gao et al. Ionic liquid decorated AIE luminogen for selective detection of HSA in biofluids and early disease screening
Gu et al. A novel fluorescent probe based on β-C-glycoside for quantification of bovine serum albumin
Caldwell et al. Coumarins to cyanines: synthesis of hemicyanines
Wang et al. Bioinspired one-pot furan-thiol-amine multicomponent reaction for making heterocycles and its applications
Фалетров et al. Interaction of nitrobenzoxadiazole derivatives of piperazine and aniline with bovine serum albumine in silico and in vitro

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant